Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,067,345
-
Share change
-
-434,233
-
Total reported value
-
$285,826,747
-
Price per share
-
$6.96
-
Number of holders
-
77
-
Value change
-
-$3,346,363
-
Number of buys
-
31
-
Number of sells
-
34
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q2 2021
As of 30 Jun 2021,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,067,345 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Bain Capital Life Sciences Investors, LLC, PICTET ASSET MANAGEMENT LTD, VANGUARD GROUP INC, SUVRETTA CAPITAL MANAGEMENT, LLC, Aisling Capital Management LP, and Nantahala Capital Management, LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.